Pfizer Inc (PFE) 35.44 $PFE Pfizer Beats Estima
Post# of 273331
Posted On: 07/28/2015 3:11:29 PM
Pfizer Inc (PFE) 35.44 $PFE
Pfizer Beats Estimates On Strong Cancer Drug Sales
at The Street - 10 mins ago
Pfizer reported earnings that beat estimates and raised its outlook for the year, as its newly launched drug treatments continued to perform well in the second quarter.
PFE: 35.44 (+1.10)
Stocks Rally as Crude Oil Closes Near $48
at The Street - 11 mins ago
Stocks move confidently higher on Tuesday as the Federal Reserve kicks off a two-day meeting and crude oil prices rebound.
F: 14.90 (+0.35), BIDU: 163.32 (-34.36), PFE: 35.44 (+1.10), XOM: 82.51 (+3.25), COP: 52.58 (+1.93), BP: 37.27 (+1.22), CVX: 92.46 (+3.32), PTR: 99.30 (+4.13), UPS: 100.25 (+5.13), XLE: 70.55 (+2.04)
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast
By LINDA A. JOHNSON - AP - 1 hr 35 mins ago
Pfizer Inc. beat Wall Street's second-quarter expectations and raised its 2015 forecast, as soaring sales for a few key products helped inoculate the world's second-largest drugmaker against a $1 billion revenue hit from foreign exchange rates and its last wave of cheap generic competition hurting former big sellers.
MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), BMY: 64.53 (+0.23)
Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal
at Investor's Business Daily - 2 hrs 8 mins ago
Big pharmas Pfizer (PFE) and Merck (MRK) both beat Q2 estimates and raised guidance Tuesday, while Merck and French counterpart Sanofi (SNY) entered into separate deals to develop immunotherapy drugs for cancer. Pfizer's earnings dipped 3% to 56...
MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), BMY: 64.53 (+0.23), SNY: 53.64 (+0.31), REGN: 555.68 (+15.65)
Stocks Turn Positive as Energy Sector Leads
at The Street - Tue Jul 28, 10:07AM CDT
Stocks bounce back to session highs by late morning Tuesday.
AMZN: 527.11 (-4.30), F: 14.90 (+0.35), HON: 104.42 (+2.78), PFE: 35.44 (+1.10), XOM: 82.51 (+3.25), COP: 52.58 (+1.93), UPS: 100.25 (+5.13), BIDU: 163.32 (-34.36), EBAY: 28.24 (+0.24), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), BP: 37.27 (+1.22), PG: 80.43 (+0.46), CVX: 92.46 (+3.32), PTR: 99.30 (+4.13), XLE: 70.55 (+2.04)
China, the Fed Coming to Grips - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Jul 28, 9:27AM CDT
Stocks appear on track to start today's session in the green with a less-worrisome Chinese stock market, the Fed meeting and a barrage of earnings reports providing a mixed backdrop.
PFE: 35.44 (+1.10), DD: 56.00 (-0.73), UPS: 100.25 (+5.13)
Pfizer (PFE) Stock Climbs on Strong Earnings
at The Street - Tue Jul 28, 8:45AM CDT
Pfizer (PFE) shares are gaining after the company reported a drop in profit and revenues that still beat analysts' expectations.
PFE: 35.44 (+1.10)
Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.44 (+1.10), INVN: 13.52 (+0.63), COP: 52.58 (+1.93), TEVA: 70.95 (-1.05), TWTR: 36.15 (+1.45)
Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Jul 28, 8:19AM CDT
Pfizer (PFE) raised the midpoint of its 2015 guidance range for revenues by $500 million and for earnings by 4 cents.
BAX: 38.08 (+0.38), PFE: 35.44 (+1.10), LLY: 85.59 (+1.44), HSP: 89.24 (-0.11)
Stock Futures Trade Higher as U.S. Home Prices Climb
at The Street - Tue Jul 28, 8:13AM CDT
Stock futures hold onto gains on Tuesday as home prices rise in May, though at a slightly slower pace than expected.
AMZN: 527.11 (-4.30), F: 14.90 (+0.35), HON: 104.42 (+2.78), PFE: 35.44 (+1.10), BIDU: 163.32 (-34.36), EBAY: 28.23 (+0.23), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), BP: 37.27 (+1.22), PG: 80.43 (+0.46)
Pfizer (PFE) Beats on Q2 Earnings and Revenues - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 7:36AM CDT
Pfizer (PFE) Beats on Q2 Earnings and Revenues
PFE: 35.44 (+1.10)
Are These 2 Big Pharmas Really Buyout Candidates?
George Budwell, The Motley Fool - Motley Fool - Tue Jul 28, 6:42AM CDT
Source: Pixabay The pharmaceutical industry is undergoing an unprecedented amount of consolidation right now due to an influx of cash from several new classes of drugs and the need to replace former blockbusters that have lost patent...
GILD: 112.47 (+1.93), PFE: 35.44 (+1.10), AZN: 32.85 (+0.14), BMY: 64.53 (+0.23)
PFIZER REPORTS SECOND-QUARTER 2015 RESULTS
Business Wire - Tue Jul 28, 6:00AM CDT
--Second-Quarter 2015 Adjusted Diluted EPS(2) of $0.56, Reported Diluted EPS(1) of $0.42
PFE: 35.44 (+1.10)
Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday
at The Street - Mon Jul 27, 7:15PM CDT
Merck, Pfizer, UPS and Twitter are among the many companies reporting earnings.
F: 14.90 (+0.35), PNRA: 184.54 (+0.53), GILD: 112.47 (+1.93), PFE: 35.44 (+1.10), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), TWTR: 36.15 (+1.45), BWLD: 170.33 (+1.76), UPS: 100.25 (+5.13)
What's in Store for Hospira (HSP) this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 3:20PM CDT
Hospira Inc. (HSP) is set to report second-quarter 2015 results on Jul 29 before the market opens.
IMDZ: 23.27 (+0.14), MDCO: 33.63 (+0.24), PFE: 35.44 (+1.10), HSP: 89.24 (-0.11)
Will Currency & Generics Weigh on Pfizer (PFE) Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 3:10PM CDT
Pfizer (PFE), which is scheduled to report its second-quarter 2015 earnings on Jul 28, had posted a positive earnings surprise of 2.00% last quarter.
MDCO: 33.63 (+0.24), PFE: 35.44 (+1.10), TEVA: 70.95 (-1.05), HSP: 89.24 (-0.11)
Will Headwinds Weigh on Glaxo's (GSK) Earnings in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 2:50PM CDT
Glaxo (GSK), which is scheduled to report its second-quarter 2015 earnings on Jul 29, had posted a negative earnings surprise of 12.73% last quarter.
PRGO: 191.04 (-2.56), PFE: 35.44 (+1.10), GSK: 41.72 (+0.12), NVS: 102.80 (+1.26)
Pfizer (PFE) Stock Falls Ahead of Earnings Release
at The Street - Mon Jul 27, 10:43AM CDT
Pfizer (PFE) shares are declining ahead of tomorrow's release of the company's second quarter earnings results.
PFE: 35.44 (+1.10)
Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings Preview: - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 8:30AM CDT
Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings Preview:
ROP: 164.86 (+0.61), MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), DD: 56.00 (-0.73)
Pfizer Beats Estimates On Strong Cancer Drug Sales
at The Street - 10 mins ago
Pfizer reported earnings that beat estimates and raised its outlook for the year, as its newly launched drug treatments continued to perform well in the second quarter.
PFE: 35.44 (+1.10)
Stocks Rally as Crude Oil Closes Near $48
at The Street - 11 mins ago
Stocks move confidently higher on Tuesday as the Federal Reserve kicks off a two-day meeting and crude oil prices rebound.
F: 14.90 (+0.35), BIDU: 163.32 (-34.36), PFE: 35.44 (+1.10), XOM: 82.51 (+3.25), COP: 52.58 (+1.93), BP: 37.27 (+1.22), CVX: 92.46 (+3.32), PTR: 99.30 (+4.13), UPS: 100.25 (+5.13), XLE: 70.55 (+2.04)
Drugmaker Pfizer tops Street 2Q forecasts, raises forecast
By LINDA A. JOHNSON - AP - 1 hr 35 mins ago
Pfizer Inc. beat Wall Street's second-quarter expectations and raised its 2015 forecast, as soaring sales for a few key products helped inoculate the world's second-largest drugmaker against a $1 billion revenue hit from foreign exchange rates and its last wave of cheap generic competition hurting former big sellers.
MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), BMY: 64.53 (+0.23)
Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal
at Investor's Business Daily - 2 hrs 8 mins ago
Big pharmas Pfizer (PFE) and Merck (MRK) both beat Q2 estimates and raised guidance Tuesday, while Merck and French counterpart Sanofi (SNY) entered into separate deals to develop immunotherapy drugs for cancer. Pfizer's earnings dipped 3% to 56...
MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), BMY: 64.53 (+0.23), SNY: 53.64 (+0.31), REGN: 555.68 (+15.65)
Stocks Turn Positive as Energy Sector Leads
at The Street - Tue Jul 28, 10:07AM CDT
Stocks bounce back to session highs by late morning Tuesday.
AMZN: 527.11 (-4.30), F: 14.90 (+0.35), HON: 104.42 (+2.78), PFE: 35.44 (+1.10), XOM: 82.51 (+3.25), COP: 52.58 (+1.93), UPS: 100.25 (+5.13), BIDU: 163.32 (-34.36), EBAY: 28.24 (+0.24), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), BP: 37.27 (+1.22), PG: 80.43 (+0.46), CVX: 92.46 (+3.32), PTR: 99.30 (+4.13), XLE: 70.55 (+2.04)
China, the Fed Coming to Grips - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Jul 28, 9:27AM CDT
Stocks appear on track to start today's session in the green with a less-worrisome Chinese stock market, the Fed meeting and a barrage of earnings reports providing a mixed backdrop.
PFE: 35.44 (+1.10), DD: 56.00 (-0.73), UPS: 100.25 (+5.13)
Pfizer (PFE) Stock Climbs on Strong Earnings
at The Street - Tue Jul 28, 8:45AM CDT
Pfizer (PFE) shares are gaining after the company reported a drop in profit and revenues that still beat analysts' expectations.
PFE: 35.44 (+1.10)
Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.44 (+1.10), INVN: 13.52 (+0.63), COP: 52.58 (+1.93), TEVA: 70.95 (-1.05), TWTR: 36.15 (+1.45)
Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Jul 28, 8:19AM CDT
Pfizer (PFE) raised the midpoint of its 2015 guidance range for revenues by $500 million and for earnings by 4 cents.
BAX: 38.08 (+0.38), PFE: 35.44 (+1.10), LLY: 85.59 (+1.44), HSP: 89.24 (-0.11)
Stock Futures Trade Higher as U.S. Home Prices Climb
at The Street - Tue Jul 28, 8:13AM CDT
Stock futures hold onto gains on Tuesday as home prices rise in May, though at a slightly slower pace than expected.
AMZN: 527.11 (-4.30), F: 14.90 (+0.35), HON: 104.42 (+2.78), PFE: 35.44 (+1.10), BIDU: 163.32 (-34.36), EBAY: 28.23 (+0.23), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), BP: 37.27 (+1.22), PG: 80.43 (+0.46)
Pfizer (PFE) Beats on Q2 Earnings and Revenues - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 7:36AM CDT
Pfizer (PFE) Beats on Q2 Earnings and Revenues
PFE: 35.44 (+1.10)
Are These 2 Big Pharmas Really Buyout Candidates?
George Budwell, The Motley Fool - Motley Fool - Tue Jul 28, 6:42AM CDT
Source: Pixabay The pharmaceutical industry is undergoing an unprecedented amount of consolidation right now due to an influx of cash from several new classes of drugs and the need to replace former blockbusters that have lost patent...
GILD: 112.47 (+1.93), PFE: 35.44 (+1.10), AZN: 32.85 (+0.14), BMY: 64.53 (+0.23)
PFIZER REPORTS SECOND-QUARTER 2015 RESULTS
Business Wire - Tue Jul 28, 6:00AM CDT
--Second-Quarter 2015 Adjusted Diluted EPS(2) of $0.56, Reported Diluted EPS(1) of $0.42
PFE: 35.44 (+1.10)
Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday
at The Street - Mon Jul 27, 7:15PM CDT
Merck, Pfizer, UPS and Twitter are among the many companies reporting earnings.
F: 14.90 (+0.35), PNRA: 184.54 (+0.53), GILD: 112.47 (+1.93), PFE: 35.44 (+1.10), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), TWTR: 36.15 (+1.45), BWLD: 170.33 (+1.76), UPS: 100.25 (+5.13)
What's in Store for Hospira (HSP) this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 3:20PM CDT
Hospira Inc. (HSP) is set to report second-quarter 2015 results on Jul 29 before the market opens.
IMDZ: 23.27 (+0.14), MDCO: 33.63 (+0.24), PFE: 35.44 (+1.10), HSP: 89.24 (-0.11)
Will Currency & Generics Weigh on Pfizer (PFE) Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 3:10PM CDT
Pfizer (PFE), which is scheduled to report its second-quarter 2015 earnings on Jul 28, had posted a positive earnings surprise of 2.00% last quarter.
MDCO: 33.63 (+0.24), PFE: 35.44 (+1.10), TEVA: 70.95 (-1.05), HSP: 89.24 (-0.11)
Will Headwinds Weigh on Glaxo's (GSK) Earnings in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 2:50PM CDT
Glaxo (GSK), which is scheduled to report its second-quarter 2015 earnings on Jul 29, had posted a negative earnings surprise of 12.73% last quarter.
PRGO: 191.04 (-2.56), PFE: 35.44 (+1.10), GSK: 41.72 (+0.12), NVS: 102.80 (+1.26)
Pfizer (PFE) Stock Falls Ahead of Earnings Release
at The Street - Mon Jul 27, 10:43AM CDT
Pfizer (PFE) shares are declining ahead of tomorrow's release of the company's second quarter earnings results.
PFE: 35.44 (+1.10)
Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings Preview: - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 8:30AM CDT
Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings Preview:
ROP: 164.86 (+0.61), MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), DD: 56.00 (-0.73)
(0)
(0)